Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Depreciation and Depletion (2016 - 2020)

Agios Pharmaceuticals (AGIO) has disclosed Depreciation and Depletion for 9 consecutive years, with $2.4 million as the latest value for Q2 2020.

  • For Q2 2020, Depreciation and Depletion rose 19.39% year-over-year to $2.4 million; the TTM value through Jun 2020 reached $8.9 million, up 13.96%, while the annual FY2025 figure was $5.2 million, 8.77% down from the prior year.
  • Depreciation and Depletion hit $2.4 million in Q2 2020 for Agios Pharmaceuticals, down from $2.5 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $2.5 million in Q1 2020 and bottomed at $1.2 million in Q1 2016.
  • Average Depreciation and Depletion over 5 years is $1.8 million, with a median of $1.7 million recorded in 2018.
  • Year-over-year, Depreciation and Depletion soared 236.76% in 2016 and then decreased 5.37% in 2017.
  • Agios Pharmaceuticals' Depreciation and Depletion stood at $1.7 million in 2016, then dropped by 5.37% to $1.6 million in 2017, then rose by 19.54% to $1.9 million in 2018, then fell by 3.25% to $1.9 million in 2019, then increased by 29.64% to $2.4 million in 2020.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $2.4 million, $2.5 million, and $1.9 million for Q2 2020, Q1 2020, and Q4 2019 respectively.